High NIHSS Values Predict Impairment of Cardiovascular Autonomic Control
Abstract
Background and Purpose—
Stroke is frequently associated with autonomic dysfunction, which causes secondary cardiovascular complications. Early diagnosis of autonomic imbalance prevents complications, but it is only available at specialized centers. Widely available surrogate markers are needed. This study tested whether stroke severity, as assessed by National Institutes of Health Stroke Scale (NIHSS) scores, correlates with autonomic dysfunction and thus predicts risk of autonomic complications.
Methods—
In 50 ischemic stroke patients, we assessed NIHSS scores and parameters of autonomic cardiovascular modulation within 24 hours after stroke onset and compared data with that of 32 healthy controls. We correlated NIHSS scores with parameters of total autonomic modulation (total powers of R-R interval [RRI] modulation; RRI standard deviation [RRI-SD], RRI coefficient of variation), parasympathetic modulation (square root of the mean squared differences of successive RRIs, RRI-high-frequency-powers), sympathetic modulation (normalized RRI-low-frequency-powers, blood pressure-low-frequency-powers), the index of sympatho-vagal balance (RRI-LF/HF-ratios), and baroreflex sensitivity.
Results—
Patients had significantly higher blood pressure and respiration, but lower RRIs, RRI-SDs, RRI coefficient of variation, square root of the mean squared differences of successive RRIs, RRI-low-frequency-powers, RRI-high-frequency-powers, RRI-total powers, and baroreflex sensitivity than did controls. NIHSS scores correlated significantly with normalized RRI-low-frequency-powers and RRI-LF/HF-ratios, and indirectly with RRIs, RRI-SDs, square root of the mean squared differences of successive RRIs, RRI-high-frequency-powers, normalized RRI-high-frequency-powers, RRI-total-powers, and baroreflex sensitivity. Spearman-Rho values ranged from 0.29 to 0.47.
Conclusions—
Increasing stroke severity was associated with progressive loss of overall autonomic modulation, decline in parasympathetic tone, and baroreflex sensitivity, as well as progressive shift toward sympathetic dominance. All autonomic changes put patients with more severe stroke at increasing risk of cardiovascular complications and poor outcome. NIHSS scores are suited to predict risk of autonomic dysregulation and can be used as premonitory signs of autonomic failure.
Autonomic cardiovascular dysfunction is common after stroke.1–8 Sympathetic hyperactivity and parasympathetic dysfunction9 may cause tachy- or bradyarrhythmias,6,7 troponin T increase,10 myocardial infarction, or sudden death11,12 depending on brain area affected by the stroke.8,12,13
Altered or reduced heart rate variability during acute stroke may be prognostically unfavorable.9,14,15 Sykora et al16 showed reduced baroreflex sensitivity (BRS), ie, compromised autonomic adjustment of heart rate and vascular tone to sudden blood pressure (BP) changes, in acute and subacute stroke patients.5,17 They concluded that sympathetic overactivity and blunted BRS predict poor prognosis after stroke.5,15,18 Thus, early diagnosis of autonomic dysregulation has prognostic and therapeutic relevance in acute stroke.5,18
However, diagnosis of impaired autonomic BP and heart rate modulation requires specific techniques and expertise that is not widely available. Therefore, easily determined clinical surrogate markers of autonomic failure are desirable.
Based on previously reported correlations between autonomic impairment and clinical deficits,4,19 we hypothesize that readily available clinical stroke scale scores may serve as a surrogate measure of increased autonomic risk in acute stroke.
To determine whether acute clinical deficits reflect risk of autonomic cardiovascular dysregulation, we studied correlations between parameters of autonomic modulation and the National Institutes of Health Stroke Scale (NIHSS) scores20 in acute stroke patients.
Patients and Methods
In 50 patients (25 women, 25 men; age 48–84 years; mean age, 66±13 years) with acute, first-ever ischemic stroke in the middle cerebral artery territory (28 left-hemispheric and 22 right-hemispheric strokes), we assessed clinical stroke severity by means of NIHSS (range, 0–42 points)20; we also monitored cardiovascular autonomic modulation within 50 minutes to 23 hours (mean, 589±444 minutes) after stroke onset. Patients with other diseases and medication that affect the autonomic nervous system were excluded from the study. Patient data were compared with those of 32 age-matched healthy controls (20 women, 12 men; mean age, 61±8 years). We recruited healthy volunteers among unaffected relatives and friends of patients and among members of our research team. The study was approved by the ethics committee of the University of Erlangen-Nuremberg.
To derive parameters of cardiovascular autonomic modulation, we recorded 5-minute time-series of R-R-interval (RRI), BP, respiratory frequency, and transcutaneous oxygen saturation (SatO2). RRIs were recorded by conventional 3-lead electrocardiography. Beat-to-beat systolic and diastolic blood pressures (BPsys, BPdia) were measured noninvasively at the index or middle finger of the nonparetic hand, using the vascular unloading technique21 (CNAPTM, Dräger Medical), then were calibrated against ipsilateral brachial artery BP.21 Respiratory frequency was recorded by chest impedance measurements. SatO2 was measured by pulse-oximetry (Dräger Medical).
All signals were sampled at 200 Hz, digitized, and stored for analysis on a custom-designed data acquisition and analysis system (SUEmpathyTM, SUESS Medizin-Technik).22
From 5-minute recordings without artifacts, we extracted the most stationary 90-second epochs, then calculated mean values and SD of all signals. To avoid a bias regarding the signal epoch selected for data analysis, we extracted the most stationary 90-second period from the 5-minute recordings while blinded to the participant's status (eg, sex, age, healthy control or patient, NIHSS score).
As autonomic parameters, we determined the coefficient of variation of RRIs (RRI-CV). RRI-CV and RRI-SD reflect sympathetic and parasympathetic cardiac modulation.23,24 We calculated square root of the mean squared differences of successive RRIs (RMSSD), reflecting parasympathetic cardiac modulation.23,24
We performed trigonometric regressive spectral analyses25 of slow, underlying RRI and BP oscillations in frequency ranges reflecting sympathetic and parasympathetic influences on RRI and BP.25
We identified peaks of oscillations in the so-called low-frequency (LF; 0.04–0.14 Hz) and high-frequency (HF; 0.15–0.50 Hz) ranges of RRI and BP modulation.23,24
LF oscillations of RRI at rest are considered to be mediated by sympathetic outflow and, to an undetermined degree, also by parasympathetic activity; meanwhile, LF oscillations of BP are related to sympathetic outflow only.23,24 HF oscillations in RRI reflect parasympathetic activity,23,24 whereas BP fluctuations in the HF range are primarily a mechanical consequence of respiration-induced fluctuations in venous return and cardiac output.23,24
The magnitude of LF and HF oscillations was determined as the integral under the power spectral density curves of RRI (ms2/Hz) and BP (mm Hg2/Hz) for the 2 frequency bands, and was expressed as LF- and HF-powers of RRI (ms2) and BP (mm Hg2).23,24
In addition, we calculated RRI-LF/HF-ratios as an index of sympatho-vagal balance, and the sum of LF- and HF-powers as an approximation of the total power of RRI oscillations and index of overall autonomic cardiac modulation.23,24 We normalized RRI-LF- and RRI-HF- powers to reduce effects of interindividual differences in total powers on absolute RRI-LF- and RRI-HF-powers,26 where RRI-LFnu=(RRI-LF/[RRI-LF+RRI−HF])×100%, and RRI-HFnu=(RRI-HF/[RRI-LF+RRI−HF])×100%.23,24 To determine BRS, the trigonometric regressive spectral software selected pairs of LF and HF oscillations of BPsys and RRI with high coherence (>0.7).27 With high coherence, the sensitivity of the baroreflex loop (ms×mm Hg−1) can be derived as gain values from changes in RRIs (ms) in relation to changes in BPsys (mm Hg).27
Statistics
For data analysis, we used a commercially available statistical program (SPSS 18.0, SPSS Inc.). We tested data for normal distribution by the Shapiro-Wilk test.
Normally distributed patient and control data were compared using the t test for unpaired samples. Non-normally distributed data were compared using the Mann-Whitney U test.
Correlations between NIHSS scores and bio-signals as well as autonomic parameters and BRS were assessed with the Spearman rank correlation test.
Using the Spearman rank correlation test, we also calculated correlations between the interval from stroke onset to autonomic testing and the NIHSS scores, and we correlated the interval with values of the recorded bio-signals and with parameters of autonomic modulation. Significance was assumed for P<0.05.
Results
In 50 stroke patients, NIHSS scores ranged from 1 to 21 (median, 5; lower quartile, 3; upper quartile, 11). Table 1 summarizes data of patients and controls.
Parameter, Mean±SD | MCA Stroke (n=50) | Control (n=32) | P |
---|---|---|---|
Age, years | 65.8 ±12.7 | 61.9 ±7.6 | 0.085* |
RRI, ms | 779.1 ±141.2† | 937.6 ±117.5† | 0.000†‡ |
RRI-SD, ms | 17.3 ±8.2† | 24.4 ±8.3† | 0.000†‡ |
RRI-CV, % | 2.2 ±1.0† | 2.6 ±0.9† | 0.021*† |
RMSSD, ms | 15.1 ±8.7† | 19.2 ±9.5† | 0.023*† |
BPsys, mm Hg | 143.3 ±27.4† | 132.2 ±18.6† | 0.048†‡ |
BPdia, mm Hg | 78.9 ±18.3 | 72.6 ±10.7 | 0.079‡ |
Respiratory frequency, min−1 | 17.0 ±3.5† | 13.6 ±4.7† | 0.000†‡ |
RRI-LF-powers, ms2 | 182.2 ±211.8† | 296.8 ±208.4† | 0.000*† |
RRI-LFnu-powers, % | 68.5 ±19.7 | 70.0 ±13.5 | 0.716‡ |
RRI-HF-powers, ms2 | 69.2 ±61.5† | 124.1 ±122.3† | 0.005*† |
RRI-HFnu-powers, % | 31.5 ±19.7 | 30.0 ±13.5 | 0.716‡ |
RRI-total powers, ms2 | 251.2 ±232.7† | 421.0 ±277.8† | 0.001*† |
RRI-LF/HF-ratios | 5.0 ±6.5 | 3.5 ±3.3 | 0.909* |
BPsys-LF-powers, mm Hg2 | 8.2 ±7.6 | 7.7 ±7.0 | 0.879* |
BPsys-HF-powers, mm Hg2 | 3.0 ±6.1 | 1.6 ±1.9 | 0.463* |
BRS, ms·mm Hg−1 | 5.3 ±2.8† | 7.0 ±3.7† | 0.023*† |
RRI, R-R interval; RRI-SD, SD of RRIs; RRI-CV, coefficient of variation of RRIs; RMSSD, square root of the mean squared differences of successive RRIs; BPsys, systolic blood pressure; BPdia, diastolic BP; LF, low frequency; HF, high frequency; nu, normalized units; RRI-LF/HF-ratios, low-frequency/high-frequency-ratios of RRIs; BRS, baroreflex sensitivity.
*
P-values derived from the nonparametric Mann-Whitney-test.
†
Significant differences between patients and controls.
‡
P-values derived from t-tests.
In patients, BPsys and respiratory frequency were significantly higher than they were in controls, whereas RRIs, RRI-SD, RRI-CV, and RMSSD were lower in patients than they were in controls (Table 1).
Similarly, patients had lower RRI-LF-powers, RRI-HF-powers, RRI-total powers, and BRS than did controls (Table 1).
BPdia values were not quite significantly higher in patients than in controls (P=0.07), while BPsys-LF-powers, BPsys-HF-powers, normalized RRI-LF-powers, normalized RRI-HF-powers, and RRI-LF/HF-ratios did not differ between patients and controls (P>0.05).
NIHSS scores correlated significantly with normalized RRI-LF-powers and RRI-LF/HF-ratios, while there were an inverse correlations between NIHSS scores and RRIs, RRI-SDs, RMSSD, RRI-HF-powers, normalized RRI-HF-powers, RRI-total powers, and BRS (for Spearman-Rho-values, see Table 2).
Parameter | Spearman Rho | P |
---|---|---|
RRI, ms | −0.310 | 0.028 |
RRI-SD, ms | −0.289 | 0.042 |
RRI-CV, % | −0.218 | 0.129 |
RMSSD, ms | −0.421 | 0.002 |
BPsys, mm Hg | −0.092 | 0.526 |
BPdia, mm Hg | −0.101 | 0.487 |
Respiratory frequency, min−1 | −0.068 | 0.641 |
O2-saturation, % | 0.067 | 0.642 |
RRI-LF-powers, ms2 | 0.177 | 0.219 |
RRI-LFnu-powers, % | 0.345 | 0.014 |
RRI-HF-powers, ms2 | −0.466 | 0.001 |
RRI-HFnu-powers, % | −0.345 | 0.014 |
RRI-total powers, ms2 | −0.292 | 0.039 |
RRI-LF/HF-ratios | 0.345 | 0.014 |
BPsys-LF-powers, mm Hg2 | −0.032 | 0.828 |
BPsys-HF-powers, mm Hg2 | 0.125 | 0.386 |
BRS, ms·mm Hg−1 | −0.317 | 0.025 |
RRI, R-R intervals; RRI-SD, standard deviation of RRI, RRI-CV, coefficient of variation of RRIs; RMSSD, square root of the mean squared differences of successive RRIs; BPsys, systolic blood pressure; BPdia, diastolic BP; LF, low frequency; HF, high frequency; nu, normalized units; RRI-LF/HF-ratio, low-frequency/high-frequency-ratio of RRIs; BRS, baroreflex sensitivity.
There were no significant correlations between NIHSS scores and BPsys, BPdia, SatO2, respiratory frequency, RRI-CV, absolute RRI-LF-powers, and BPsys-LF-powers.
There was no significant correlation between NIHSS scores and the interval from stroke onset to autonomic testing (Spearman Rho, 0.218; P=0.128).
Moreover, there were no significant correlations between this interval and RRIs, BPsys and BPdia, respiratory frequency, SatO2, RRI-SDs, RRI-CVs, RRI-LF-powers, RRI-LF/HF-ratios, normalized RRI-LF- and RRI-HF-powers, BPsys-LF-powers, BPsys-HF-powers, and BRS. In contrast, the interval correlated with the parasympathetic indices RMSSD of RRIs (Rho=0.308; P=0.029), RRI-HF-powers (Rho=0.415; P=0.003), and with the index of overall autonomic cardiac modulation, the sum of RRI-LF-powers and RRI-HF-powers (RRI-total powers; Rho=0.284; P=0.046).
Discussion
Our stroke patients had higher BP, heart rate, and respiratory frequency than did controls, indicating increased sympathetic cardiovascular modulation.6,7,9,28–30 However, the lower RRI-LF-powers, lower sympathetically and parasympathetically mediated RRI-SDs, RRI-CVs, and RRI-total powers23,24 in patients than in controls show a general loss of autonomic cardiac modulation; this has been reported in previous stroke studies.6,7,28 In contrast to the increase in BP, heart rate, and respiratory frequency of our patients, similar RRI-LF/HF-ratios between patients and controls seem to suggest that there is no major change in sympatho-vagal balance after stroke. Yet, increasing RRI-LF/HF-ratios in patients with higher NIHSS scores, as well as the lower RMSSDs and RRI-HF-powers in patients than in controls, confirm a loss in parasympathetic modulation after stroke, and predominant sympathetic tone with increasing stroke severity.
Previous studies support the conclusion that autonomic imbalance depends on stroke severity. Korpelainen et al4 report no increase in RRI-LF/HF-ratios in patients with stroke severity similar to that of our patients.4,31 In contrast, Tokgözoglu et al found increased RRI-LF/HF-ratios in patients who had higher NIHSS scores than did our patients.6
The correlations seen in our patients between NIHSS scores and parameters of autonomic modulation (Figure) indicate a higher risk of autonomic complications in patients with more severe strokes. Tokgözoglu et al observed an association between sudden death and reduced parasympathetic, but increased sympathetic activity in their 62 stroke patients.6 The 7 patients who died unexpectedly during hospitalization had higher RRI-LF/HF-ratios than did surviving patients.6 Among 44 stroke patients, Orlandi et al found increased RRI-LF/HF-ratios in the 31 patients with arrhythmias.7
Sympathetic predominance increases the risk of poststroke tachyarrhythmias,6,7 myocardial infarctions,10,12 myofibrillary necrosis, perivascular and interstitial fibrosis, and myocyte vacuolization10,32; it additionally increases the risk of secondary brain injury and edema caused by sympathetically driven inflammation with fever, hyperglycemia, polycythemia, and increased blood-brain barrier permeability.18,33 Consequently, increased sympathetic outflow compromises stroke outcome.29
The progressive decline in parasympathetic activity in our patients with more severe strokes adds to the risk of cardiovascular and cerebral complications.34 Parasympathetic deficiency promotes malignant tachyarrhythmias8,13,34,35 and mortality,36 reduces cerebral vasodilatation in animal stroke studies, and subsequently furthers cerebral vasoconstriction37 and secondary brain damage.38
The overall loss in autonomic modulation, ie, the decreasing RRI-SDs and RRI-total powers in patients with higher NIHSS scores, is associated with a growing risk of cardiac complications and sudden death.14,39
Declining autonomic modulation predicts poor outcome, as shown in patients with myocardial infarction,40 chronic heart failure,41 multiple organ dysfunction syndrome,42 and in ischemic stroke.4,14
Progressive loss in autonomic modulation in patients with more severe stroke also causes deteriorating heart rate and BP adjustment to instantaneous changes of either parameter because of declining BRS.17 Sykora et al showed that BRS impairment depends on the volume of the stroke and involvement of the insula16; they confirm the conclusions of Robinson et al that BRS deterioration after stroke reflects central autonomic dysfunction.15 Similar to our results, Sykora et al found correlations between decreasing BRS and increasing NIHSS scores.19
Reduced BRS is associated with poor outcome in cardiac, renal, or metabolic diseases,40,43 and in stroke.5,15 According to Robinson et al, BRS impairment during acute stroke is associated with a 4.5-fold increase in mortality rates.15 Baroreflex failure results in increased BP fluctuations44 that may exceed cerebral autoregulation buffering capacity45; this causes secondary cerebral lesions,46 particularly in patients with more severe stroke and more deficient BRS. BP fluctuations worsen stroke outcome, as they cause more severe end-organ damage than does nonfluctuating arterial hypertension.47
In our patients, coefficients of correlation between increasing NIHSS scores and deteriorating autonomic parameters range from Spearman Rho values of 0.29 to 0.47. Still, the high consistency of correlations between stroke severity and all measures of autonomic dysregulation confirms that more severe stroke is associated with more pronounced autonomic failure and subsequent risk of secondary cardiovascular6,7,10,12,18,29,30 or cerebral complications.18,33,37,38
Study Limitations
The rather wide interval between stroke onset and autonomic testing, from 50 minutes to 23 hours, might bias our results. However, NIHSS scores were not dependent on the interval between stroke onset and autonomic evaluation. In contrast, there seems to be inconsistent correlations between this interval and some of the autonomic parameters. Particularly, the positive correlation of the interval between stroke onset and autonomic testing with the parasympathetic parameters RMSSD and RRI-HF-powers suggests that parasympathetic modulation recovers with increasing time since stroke onset. Moreover, the correlation of the interval with overall autonomic modulation points toward the potential for regaining autonomic control over time. The findings encourage follow-up assessments of autonomic control to determine the duration and time course of autonomic dysfunction.
Although we found significant correlations between NIHSS scores and parameters of cardiovascular autonomic dysfunction, there is substantial variability within these correlations. We assume that this variability is because of the effects of age and sex on autonomic parameters, and because of the difference between discontinuous NIHSS scoring and continuous values of autonomic function.
In contrast to continuous values of autonomic parameters, the NIHSS is designed as a straightforward scoring system that assigns noncontinuous scores to the major clinical deficiencies without reflecting the entire scope of deficits in an individual stroke patient (eg, apraxias and neurocognitive deficits).20,48 Consequently, stroke severity may be categorized by the same NIHSS score in patients with a different extent or location of the neurological lesion. In contrast, involvement of different parts of the central autonomic network most likely accounts for differences in autonomic dysfunction and thus different values of parameters reflecting dysautonomia.49
Moreover, most autonomic parameters vary with differences in age and sex,50,51 while NIHSS scores are independent of the patient's sex or age. The age range of our patients was rather wide (48 to 84 years) and very likely contributed to the variation in autonomic parameters, regardless of NIHSS scores. Similarly, differences in sex, with 25 male and 25 female stroke patients, contribute to the variation in autonomic parameters, again regardless of the NIHSS score.50,51
The variability of autonomic parameters demonstrates the need for refined autonomic testing in stroke patients. Yet, the methodology is not readily available. Despite the rather wide variability of autonomic parameters for a given NIHSS score, the consistency of correlations between the autonomic parameters and NIHSS scores still supports the conclusion that NIHSS scoring may serve as a coarse substitute for sophisticated autonomic assessment.
In summary and in conformity with previous studies,4–7,14,15,28 our results demonstrate the need for autonomic monitoring of stroke patients to prevent complications caused by autonomic failure.
However, autonomic monitoring is not widely available; and yet, NIHSS scores are easily taken. From the correlations seen in our patients, we suggest that NIHSS scores may serve as surrogate markers of progressive autonomic failure. Deteriorating NIHSS scores require close observation of heart rate, BP, and the variabilities of those measures. Loss of heart rate variability and increasing BP variability indicate growing autonomic risk and predict the need for interventions to stabilize the cardiovascular system.
Perspective
There are many reports about differences in autonomic dysfunction after left- and right-sided stroke.2,3,6,8,29,52 Although many studies found a shift toward more prominent sympathetic modulation after right-hemispheric stroke,8,11,29,52,53 there are also reports that only found a decrease in total autonomic modulation4 or a decrease in parasympathetic outflow after right-hemispheric stroke.2,54 Moreover, NIHSS scores are higher with left-sided than with right-sided stroke.48,55–59
Therefore, we assume that the correlations seen between NIHSS scores and autonomic parameters might be hemisphere-dependent. Hemispheric predominance of autonomic modulation35 might account for discrepancies of autonomic dysfunction and of its correlation with NIHSS scores between patients with right and left middle cerebral artery stroke. A preliminary analysis of our hemisphere-specific data suggests there are quite complex and intricate interactions between the side of the lesion and the dysautonomia. Yet, it is beyond the scope of this article to present and discuss the hemisphere-specific data. We, however, intend to provide a separate detailed analysis of hemispheric correlations and differences.
Supplemental Material
Sources of Funding
The study was supported by Sanofi-Aventis, GmbH, Germany, the Rolf und Hubertine Schiffbauer-Stiftung, Hof, Germany, and the International Brain Research Foundation, Edison, NJ.
References
1.
Barron SA, Rogovski Z, Hemli J. Autonomic consequences of cerebral hemisphere infarction. Stroke. 1994; 25: 113–116.
2.
Naver HK, Blomstrand C, Wallin BG. Reduced heart rate variability after right-sided stroke. Stroke. 1996; 27: 247–251.
3.
Klingelhofer J, Sander D. Cardiovascular consequences of clinical stroke. Baillieres Clin Neurol. 1997; 6: 309–335.
4.
Korpelainen JT, Sotaniemi KA, Huikuri HV, Myllya VV. Abnormal heart rate variability as a manifestation of autonomic dysfunction in hemispheric brain infarction. Stroke. 1996; 27: 2059–2063.
5.
Sykora M, Diedler J, Turcani P, Hacke W, Steiner T. Baroreflex: A new therapeutic target in human stroke? Stroke. 2009; 40: e678–682.
6.
Tokgozoglu SL, Batur MK, Top uoglu MA, Saribas O, Kes S, Oto A. Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke. 1999; 30: 1307–1311.
7.
Orlandi G, Fanucchi S, Strata G, Pataleo L, Landucci Pellegrini L, Prontera C, Martini A, Murri L. Transient autonomic nervous system dysfunction during hyperacute stroke. Acta Neurol Scand. 2000; 102: 317–321.
8.
Dutsch M, Burger M, Dorfler C, Schwab S, Hilz MJ. Cardiovascular autonomic function in poststroke patients. Neurology. 2007; 69: 2249–2255.
9.
Korpelainen JT, Sotaniemi KA, Myllyla VV. Autonomic nervous system disorders in stroke. Clin Auton Res. 1999; 9: 325–333.
10.
Ay H, Koroshetz WJ, Benner T, Vangel MG, Melinosky C, Arsava EM, Ayata C, Zhu M, Schwamm LH, Sorensen AG. Neuroanatomic correlates of stroke-related myocardial injury. Neurology. 2006; 66: 1325–1329.
11.
Oppenheimer S. Cerebrogenic cardiac arrhythmias: Cortical lateralization and clinical significance. Clin Auton Res. 2006; 16: 6–11.
12.
Rincon F, Dhamoon M, Moon Y, Paik MC, Boden-Albala B, Homma S, Di Tullio MR, Sacco RL, Elkind MS. Stroke location and association with fatal cardiac outcomes: Northern manhattan study (nomas). Stroke. 2008; 39: 2425–2431.
13.
Hilz MJ, Schwab S. Stroke-induced sudden-autonomic death: Areas of fatality beyond the insula. Stroke. 2008; 39: 2421–2422.
14.
Makikallio AM, Makikallio TH, Korpelainen JT, Sotaniemi KA, Huikuri HV, Myllyla VV. Heart rate dynamics predict poststroke mortality. Neurology. 2004; 62: 1822–1826.
15.
Robinson TG, Dawson SL, Eames PJ, Panerai RB, Potter JF. Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke. 2003; 34: 705–712.
16.
Sykora M, Diedler J, Rupp A, Turcani P, Steiner T. Impaired baroreceptor reflex sensitivity in acute stroke is associated with insular involvement, but not with carotid atherosclerosis. Stroke. 2009; 40: 737–742.
17.
Eckberg DL, Sleight P. Human Baroreflexes in Health and Disease. New York, NY: Oxford University Press. 1992.
18.
Sykora M, Diedler J, Rupp A, Turcani P, Rocco A, Steiner T. Impaired baroreflex sensitivity predicts outcome of acute intracerebral hemorrhage. Crit Care Med. 2008; 36: 3074–3079.
19.
Sykora M, Diedler J, Poli S, Rupp A, Turcani P, Steiner T. Blood pressure course in acute stroke relates to baroreflex dysfunction. Cerebrovasc Dis. 2010; 30: 172–179.
20.
Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol. 2006; 5: 603–612.
21.
Bogert LW, van Lieshout JJ. Non-invasive pulsatile arterial pressure and stroke volume changes from the human finger. Exp Physiol. 2005; 90: 437–446.
22.
Friedrich C, Rudiger H, Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schols L, Berg D, Reichmann H, Ziemssen T. Baroreflex sensitivity and power spectral analysis during autonomic testing in different extrapyramidal syndromes. Mov Disord. 2010; 25: 315–324.
23.
Task force of the european society of cardiology and the north american society of pacing and electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Circulation. 1996; 93: 1043–1065.
24.
Hilz MJ. Quantitative autonomic functional testing in clinical trials. In:, Brown R, Bolton C, Aminoff M eds. Neuromuscular function and disease. Philadelphia: W.B. Saunders Company. 2002; 1899–1929.
25.
Rudiger H, Klinghammer L, Scheuch K. The trigonometric regressive spectral analysis- a method for mapping of beat-to-beat recorded cardiovascular parameters on to frequency domain compared with fourier transformation. Comput Methods Programs Biomed. 1999; 58: 1–15.
26.
Bernardi L, Bianchini B, Spadacini G, Leuzzi S, Valle F, Marchesi E, Passino C, Calciati A, Vigano M, Rinaldi M, Martinelli L, Finardi G, Sleight P. Demonstrable cardiac reinnervation after human heart transplantation by carotid baroreflex modulation of rr interval. Circulation. 1995; 92: 2895–2903.
27.
Krause M, Rudiger H, Bald M, Nake A, Paditz E. Autonomic blood pressure control in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2009; 10: 255–263.
28.
Kuriyama N, Mizuno T, Niwa F, Watanabe Y, Nakagawa M. Autonomic nervous dysfunction during acute cerebral infarction. Neurol Res. 2010; 32: 821–827.
29.
Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B. Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology. 2001; 57: 833–838.
30.
Micieli G, Cavallini A. The autonomic nervous system and ischemic stroke: A reciprocal interdependence. Clin Auton Res. 2008; 18: 308–317.
31.
De Haan R, Horn J, Limburg M, Van Der Meulen J, Bossuyt P. A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke. 1993; 24: 1178–1181.
32.
Natelson BH, Suarez RV, Terrence CF, Turizo R. Patients with epilepsy who die suddenly have cardiac disease. Arch Neurol. 1998; 55: 857–860.
33.
Ay H, Arsava EM, Koroshetz WJ, Sorensen AG. Middle cerebral artery infarcts encompassing the insula are more prone to growth. Stroke. 2008; 39: 373–378.
34.
La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, Bigger JT, Camm AJ, Schwartz PJ. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials. Circulation. 2001; 103: 2072–2077.
35.
Hilz MJ, Dutsch M, Perrine K, Nelson PK, Rauhut U, Devinsky O. Hemispheric influence on autonomic modulation and baroreflex sensitivity. Ann Neurol. 2001; 49: 575–584.
36.
Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999; 341: 1351–1357.
37.
Toda N, Ayajiki K, Tanaka T, Okamura T. Preganglionic and postganglionic neurons responsible for cerebral vasodilation mediated by nitric oxide in anesthetized dogs. J Cereb Blood Flow Metab. 2000; 20: 700–708.
38.
Kano M, Moskowitz MA, Yokota M. Parasympathetic denervation of rat pial vessels significantly increases infarction volume following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1991; 11: 628–637.
39.
Liew R. Prediction of sudden arrhythmic death following acute myocardial infarction. Heart. 2010; 96: 1086–1094.
40.
La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Atrami (autonomic tone and reflexes after myocardial infarction) investigators. Lancet. 1998; 351: 478–484.
41.
Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the united kingdom heart failure evaluation and assessment of risk trial (uk-heart). Circulation. 1998; 98: 1510–1516.
42.
Schmidt H, Muller-Werdan U, Hoffmann T, Francis DP, Piepoli MF, Rauchhaus M, Prondzinsky R, Loppnow H, Buerke M, Hoyer D, Werdan K. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med. 2005; 33: 1994–2002.
43.
Johansson M, Gao SA, Friberg P, Annerstedt M, Carlstrom J, Ivarsson T, Jensen G, Ljungman S, Mathillas O, Nielsen FD, Strombom U. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure. J Hypertens. 2007; 25: 163–168.
44.
Mancia G, Parati G, Pomidossi G, Casadei R, Di Rienzo M, Zanchetti A. Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension. 1986; 8: 147–153.
45.
Diehl RR, Linden D, Lucke D, Berlit P. Phase relationship between cerebral blood flow velocity and blood pressure. A clinical test of autoregulation Stroke. 1995; 26: 1801–1804.
46.
Butcher K, Christensen S, Parsons M, De Silva DA, Ebinger M, Levi C, Jeerakathil T, Campbell BC, Barber PA, Bladin C, Fink J, Tress B, Donnan GA, Davis SM. Post thrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke. 2010; 41: 72–77.
47.
Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010; 375: 895–905.
48.
Fink JN, Frampton CM, Lyden P, Lees KR. Does hemispheric lateralization influence functional and cardiovascular outcomes after stroke?: An analysis of placebo-treated patients from prospective acute stroke trials. Stroke. 2008; 39: 3335–3340.
49.
Benarroch EE. Central autonomic network: Functional organization and clinical correlations. Armonk, NY: Futura Publishing Company, Inc. 1997.
50.
Novak V, Novak P, Low PA. Time-frequency analysis of cardiovascular function and its clinical applications. In:, Low PA ed. Clinical autonomic disorders. Philadelphia: Lippincott-Raven. 1997; 323–348.
51.
Low PA. The effect of aging on the autonomic nervous system. In:, Low PA ed. Clinical autonomic disorders. Philadelphia: Lippincott-Raven. 1997; 161–175.
52.
Meyer S, Strittmatter M, Fischer C, Georg T, Schmitz B. Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex. Neuroreport. 2004; 15: 357–361.
53.
Strittmatter M, Meyer S, Fischer C, Georg T, Schmitz B. Location-dependent patterns in cardio-autonomic dysfunction in ischaemic stroke. Eur Neurol. 2003; 50: 30–38.
54.
Oppenheimer SM, Kedem G, Martin WM. Left-insular cortex lesions perturb cardiac autonomic tone in humans. Clin Auton Res. 1996; 6: 131–140.
55.
Lyden P, Claesson L, Havstad S, Ashwood T, Lu M. Factor analysis of the national institutes of health stroke scale in patients with large strokes. Arch Neurol. 2004; 61: 1677–1680.
56.
Yoo AJ, Romero J, Hakimelahi R, Nogueira RG, Rabinov JD, Pryor JC, Gonzalez RG, Hirsch JA, Schaefer PW. Predictors of functional outcome vary by the hemisphere of involvement in major ischemic stroke treated with intra-arterial therapy: A retrospective cohort study. BMC Neurol. 2010; 10: 25.
57.
Di Legge S, Saposnik G, Nilanont Y, Hachinski V. Neglecting the difference: Does right or left matter in stroke outcome after thrombolysis? Stroke. 2006; 37: 2066–2069.
58.
Woo D, Broderick JP, Kothari RU, Lu M, Brott T, Lyden PD, Marler JR, Grotta JC. Does the national institutes of health stroke scale favor left hemisphere strokes? Ninds t-pa stroke study group Stroke. 1999; 30: 2355–2359.
59.
Fink JN, Selim MH, Kumar S, Silver B, Linfante I, Caplan LR, Schlaug G. Is the association of national institutes of health stroke scale scores and acute magnetic resonance imaging stroke volume equal for patients with right- and left-hemisphere ischemic stroke? Stroke. 2002; 33: 954–958.
Information & Authors
Information
Published In
Copyright
© 2011 American Heart Association, Inc.
Versions
You are viewing the most recent version of this article.
History
Received: 4 November 2010
Accepted: 29 December 2010
Published online: 14 April 2011
Published in print: June 2011
Keywords
Subjects
Authors
Disclosures
None.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Crosstalk between brain and the heart, Brain and Organ Communication, (45-64), (2025).https://doi.org/10.1016/B978-0-443-22268-9.00003-X
- Exploring Relationships of Heart Rate Variability, Neurological Function, and Clinical Factors with Mortality and Behavioral Functional Outcome in Patients with Ischemic Stroke, Diagnostics, 14, 12, (1304), (2024).https://doi.org/10.3390/diagnostics14121304
- Left ventricular systolic dysfunction predicts clinical prognosis in patients with acute ischemic stroke after intravenous thrombolysis, Aging, (2024).https://doi.org/10.18632/aging.205786
- Factors influencing the prognosis of patients with acute cerebral infarction who received usual care: a multicenter prospective cohort study, Journal of Physical Therapy Science, 36, 6, (352-358), (2024).https://doi.org/10.1589/jpts.36.352
- Blood Pressure Fluctuation During 72 Hours After Endovascular Therapy and Prognosis in Acute Ischemic Stroke Patients, Journal of Endovascular Therapy, (2024).https://doi.org/10.1177/15266028241266235
- Autonomic dysfunction and treatment strategies in intracerebral hemorrhage, CNS Neuroscience & Therapeutics, 30, 2, (2024).https://doi.org/10.1111/cns.14544
- Blood pressure variability at rest and during pressor challenges in patients with acute ischemic stroke, Blood Pressure Monitoring, 29, 5, (232-241), (2024).https://doi.org/10.1097/MBP.0000000000000710
- Exploring the Utility of Autonomic Nervous System Evaluation for Stroke Prognosis, Neurology International, 15, 2, (661-696), (2023).https://doi.org/10.3390/neurolint15020042
- Heart Rate Variability for Outcome Prediction in Intracerebral and Subarachnoid Hemorrhage: A Systematic Review, Journal of Clinical Medicine, 12, 13, (4355), (2023).https://doi.org/10.3390/jcm12134355
- Clinical efficacy of Danshen preparation in the treatment of vascular cognitive impairment: A systematic review and meta-analysis, Frontiers in Aging Neuroscience, 14, (2023).https://doi.org/10.3389/fnagi.2022.1090665
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.